Scott N. Braunstein
Independent DirectorDr. Scott N. Braunstein, M.D is Scientific Advisor of Vascarta Inc. Dr. Braunstein serves as Chief Executive Officer, President & Chairman of Marinus Pharmaceuticals, Inc. since November 2022. At Marinus Pharmaceuticals, Inc., he also served as Chief Executive Officer, President & Director from August 2019 to November 2022, as Executive Chairman from February 24, 2019, to August 2019 and as Director from September 7, 2018 to February 24, 2019. He is the Founder of In Situ Healthcare Consulting. He serves as Chairman of the Board at Ray Therapeutics, Inc. since January 2026. He serves as Chairman of the Board of Aegle Therapeutics Corporation since July 2025. He served as Independent Vice Chairman since November 4, 2025 until September 11, 2026 and was its Lead Independent Director at AtaiBeckley Inc. until September 11, 2026 At AtaiBeckley Inc., he also served as an Independent Member of the Supervisory Board since May 2024 and served as an Independent Director until November 4, 2025. He serves as an Independent Director at Caribou Biosciences, Inc. since June 2021. He serves as Operating Partner at Aisling Capital Management LP, which he joined on August 10, 2015. He serves as a Director at SiteOne Therapeutics, Inc., a Director at STAT Medical and a Director of the Cornell Alumni Association for the College of Agriculture and Life Sciences. Previously, Dr. Braunstein served as a Director at RAPT Therapeutics, Inc. from June 23, 2025, to March 3, 2026. He served as Lead Independent Director from November 9, 2023 and as Independent Director from September 27, 2018, to November 9, 2023 at Trevena, Inc. He served as an Independent Director at Constellation Pharmaceuticals, Inc. from February 19, 2019, to July 15, 2021. He served as an Independent Director at Alaunos Therapeutics, Inc. from September 2018 to November 19, 2020. He served as Chairman of the Board from June 2018 and as an Independent Director from May 2018 to July 20, 2020, at Protara Therapeutics, Inc. He served as an Independent Director at Esperion Therapeutics, Inc. from June 2015 to March 14, 2020. He served as Chief Operating Officer from December 7, 2017, to March 27, 2018 and as Senior Vice President of Strategy & Corporate Development from July 14, 2015 to December 6, 2017 at Pacira BioSciences, Inc. He served as Chief Operating Officer from December 6, 2017, to March 27, 2018, as Chief Strategy Officer from July 2015 to March 2018 and as Senior Vice President of Strategy & Corporate Development from July 14, 2015, to December 6, 2017 at Pacira Pharmaceuticals, Inc. He was a Money Manager at Point72 Asset Management, L.P. He served as Healthcare Portfolio Manager at EverPoint Asset Management, LLC from September 2014 to February 2015. He served as Chief Operating Officer at Stat Medical Services Inc. from September 2014 to February 2015. He served as Managing Director, Healthcare Analyst and Portfolio Manager at JP Morgan Asset Management from 2002 to 2014. He served as Research Analyst at Deutsche Bank AG, Research Division and was in healthcare specialty sales at Deutsche Bank from 2000 to 2002. He was Vice President of Operations at Defined Healthcare. He served as a Director at Proteon Therapeutics, Inc. He began his career as a physician at the Summit Medical Group and as Assistant Clinical Professor at Albert Einstein College of Medicine and for Columbia University Medical Center. Dr. Braunstein received an M.D. from Albert Einstein College of Medicine and a Bachelor's in Applied Science & Biology from Cornell University. He completed his residency in internal medicine at Cornell University-New York Hospital.
Positions
- Company NameCaribou Biosciences, Inc.Stock CodeCRBUPositionIndependent DirectorColleagues
- RERachel E. HaurwitzCo-Founder, CEO, President & Director
- ALAndrew L. GuggenhimeIndependent Chairman
- SRSriram RyaliChief Financial Officer
- BGBarbara G. McClungChief Legal Officer & Corporate Secretary
- JAJennifer A. DoudnaCo-founder & Member of Scientific Advisory Board
- RFRyan FischesserInterim Principal Accounting Officer & Controller
- NSNatalie SacksIndependent Director
